Investigators in Spain have concluded that high serum neurofilament light chain levels confirmed within the first year of a diagnosis of multiple sclerosis are associated with long-term disease worsening.
Researchers assessing the structural and pathological relationships with patient-reported outcomes in patients with MS found that outcomes related to lower limb limitations are significantly associated with neurodegenerative changes within the deep grey matter.
That was the question that formed the basis of a study from Australia, which found that people with multiple sclerosis are more likely than people without MS to have widespread deposits of potentially toxic elements in their brains.
Not much is known about the relationship between measures of spinal cord atrophy and daily physical activity levels among patients with multiple sclerosis. A team of San Francisco-based researchers set out to change that.
Researchers in Spain recently explored the long-term outcomes of patients who developed progression independent of relapse activity after a first demyelinating event in multiple sclerosis.
A survey of people with multiple sclerosis was conducted before and during the COVID-19 pandemic. The use of telemedicine increased from 25% to 80% during the pandemic, and a large proportion of participants want to continue telemedicine services for their MS care.
This retrospective cohort study of patients with MS found that Black American patients had a higher prevalence of uncontrolled hypertension than White Americans, but were also more likely to be receiving therapy for it.